Patent Assignment
Reel/Frame 044819/0243
Entity Conversion
Recorded: 2017-12-15
Pages: 3
Assignor
RUGA CORPORATION
Executed: 2016-11-03
Assignee
ARAVIVE BIOLOGICS, INC.
1221 MCKINNEY, STE. 3200, LYONDELLBASELL TOWER, HOUSTON, TEXAS, 77010
Covered Property
(1)
Modified Axl Peptides and Their Use in Inhibition of Axl Signaling in Anti-Metastatic Therapy
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 18, 2017
From: GIACCIA, AMATO J.; RANKIN, ERINN BRUNO; COCHRAN, JENNIFER R.; JONES, DOUGLAS
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 043897/0460 →
Assignment of Assignor's Interest
Oct 18, 2017
From: HERSHENSON, SUSAN
To: RUGA CORPORATION
Reel/Frame 043897/0516 →